TY - JOUR
T1 - Relationships between systemic vascular resistance, blood rheology and nitric oxide in children with sickle cell anemia or sickle cell-hemoglobin C disease
AU - Lamarre, Yann
AU - Hardy-Dessources, Marie Dominique
AU - Romana, Marc
AU - Lalanne-Mistrih, Marie Laure
AU - Waltz, Xavier
AU - Petras, Marie
AU - Doumdo, Lydia
AU - Blanchet-Deverly, Anne
AU - Martino, Jean
AU - Tressières, Benoît
AU - Maillard, Frederic
AU - Tarer, Vanessa
AU - Etienne-Julan, Maryse
AU - Connes, Philippe
N1 - Publisher Copyright:
© 2014 IOS Press and the authors. All rights reserved.
PY - 2014
Y1 - 2014
N2 - Vascular function has been found to be impaired in patients with sickle cell disease (SCD). The present study investigated the determinants of systemic vascular resistance in two main SCD syndromes in children: sickle cell anemia (SCA) and sickle cell-hemoglobin C disease (SCC). Nitric oxide metabolites (NOx), hematological, hemorheological, and hemodynamical parameters were investigated in 61 children with SCA and 49 children with SCC. While mean arterial pressure was not different between SCA and SCC children, systemic vascular resistance (SVR) was greater in SCC children. Although SVR and blood viscosity (ηb) were not correlated in SCC children, the increase of ηb (+18%) in SCC children compared to SCA children results in a greater mean SVR in this former group. SVR was positively correlated with ηb, hemoglobin (Hb) level and RBC deformability, and negatively with NOx level in SCA children. Multivariate linear regression model showed that both NOx and Hb levels were independently associated with SVR in SCA children. In SCC children, only NOx level was associated with SVR. In conclusion, vascular function of SCC children seems to better cope with higher ηb compared to SCA children. Since the occurrence of vaso-occlusive like complications are less frequent in SCC than in SCA children, this finding suggests a pathophysiological link between the vascular function alteration and these clinical manifestations. In addition, our results suggested that nitric oxide metabolism plays a key role in the regulation of SVR, both in SCA and SCC.
AB - Vascular function has been found to be impaired in patients with sickle cell disease (SCD). The present study investigated the determinants of systemic vascular resistance in two main SCD syndromes in children: sickle cell anemia (SCA) and sickle cell-hemoglobin C disease (SCC). Nitric oxide metabolites (NOx), hematological, hemorheological, and hemodynamical parameters were investigated in 61 children with SCA and 49 children with SCC. While mean arterial pressure was not different between SCA and SCC children, systemic vascular resistance (SVR) was greater in SCC children. Although SVR and blood viscosity (ηb) were not correlated in SCC children, the increase of ηb (+18%) in SCC children compared to SCA children results in a greater mean SVR in this former group. SVR was positively correlated with ηb, hemoglobin (Hb) level and RBC deformability, and negatively with NOx level in SCA children. Multivariate linear regression model showed that both NOx and Hb levels were independently associated with SVR in SCA children. In SCC children, only NOx level was associated with SVR. In conclusion, vascular function of SCC children seems to better cope with higher ηb compared to SCA children. Since the occurrence of vaso-occlusive like complications are less frequent in SCC than in SCA children, this finding suggests a pathophysiological link between the vascular function alteration and these clinical manifestations. In addition, our results suggested that nitric oxide metabolism plays a key role in the regulation of SVR, both in SCA and SCC.
KW - Blood rheology
KW - nitric oxide
KW - sickle cell disease
KW - vascular function
UR - http://www.scopus.com/inward/record.url?scp=84916879811&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84916879811&partnerID=8YFLogxK
U2 - 10.3233/CH-121661
DO - 10.3233/CH-121661
M3 - Article
C2 - 23302597
AN - SCOPUS:84916879811
SN - 1386-0291
VL - 58
SP - 307
EP - 316
JO - Clinical hemorheology and microcirculation
JF - Clinical hemorheology and microcirculation
IS - 2
ER -